Pulse Biosciences Inc EV / EBITDA
Cos'è EV / EBITDA di Pulse Biosciences Inc?
EV / EBITDA di Pulse Biosciences Inc è N/A
Qual è la definizione di EV / EBITDA?
EV / EBITDA è il valore aziendale diviso per guadagni prima di interessi, tasse, deprezzamento e ammortamento. È una misura di quanto sia costosa una azione ed è più frequentemente valida per i confronti tra le aziende rispetto al rapporto prezzo / guadagno. Misura il prezzo (sotto forma di valore d'impresa) che un investitore paga a vantaggio del flusso di cassa della società (sotto forma di EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA di aziende nel Health Care settore su NASDAQ rispetto a Pulse Biosciences Inc
Cosa fa Pulse Biosciences Inc?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Aziende con ev / ebitda simili a Pulse Biosciences Inc
- Terramin Australia ha EV / EBITDA di N/A
- Danakali ha EV / EBITDA di N/A
- Prospect Park Capital ha EV / EBITDA di N/A
- Altura Mining ha EV / EBITDA di N/A
- Redstar Gold ha EV / EBITDA di N/A
- Aminex Plc ha EV / EBITDA di N/A
- Pulse Biosciences Inc ha EV / EBITDA di N/A
- Nova Cannabis ha EV / EBITDA di N/A
- GT Gold ha EV / EBITDA di N/A
- Nanoxplore Inc ha EV / EBITDA di N/A
- Cervantes ha EV / EBITDA di N/A
- SolGold Plc ha EV / EBITDA di N/A
- Sailfish Royalty ha EV / EBITDA di N/A